Uncategorized

Novo Nordisk Warns of First Sales Drop Since Start of Ozempic

The once high-flying Danish drugmaker has struggled to fend off rivals in the weight-loss industry and faces lower prices for its medicines under a deal with President Trump.

Related posts
Uncategorized

Maryland Is First to Ban A.I.-Driven Price Increases in Grocery Stores

A state law that goes into effect in October prohibits grocery stores and third-party delivery…
Read more
Uncategorized

Oil Cools Slightly After a 4-Year High as Gasoline Jumps

The price of Brent crude, the international benchmark, dipped, while the average price of gasoline…
Read more
Uncategorized

F.D.A. Grants Early Access to Promising Drug for Pancreatic Cancer

Patients with one of the deadliest cancers have been pleading for an unapproved treatment that may…
Read more
Newsletter
Become a Trendsetter
Sign up for Davenport’s Daily Digest and get the best of Davenport, tailored for you.

Leave a Reply

Your email address will not be published. Required fields are marked *